Journal: Oncology Letters
Article Title: Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway
doi: 10.3892/ol.2020.11958
Figure Lengend Snippet: CCAT2-knockdown inhibits TCF7L2 via miR-217, thereby inhibiting the Wnt/β-catenin signaling pathway. PCa DU145 and PC3 cells were treated with si-NC, si-CCAT2, TCFL2, si-CCAT2+ TCFL2 or si-CCAT2 + LiCl. (A) The TOPflash assay was used to measure Wnt/β-catenin signaling activity. Western blotting was performed to detect the expression levels of TCF7L2, β-catenin, c-Myc and CyclinD1 in PCa (B and C) DU145 and (D and E) PC3 cells. Data are presented as the mean ± SD (n=3). *P<0.05 vs. si-NC; # P<0.05 vs. si-CCAT2. CCAT2, colon cancer associated transcript 2; TCF7L2, transcription factor 7 like 2; miR, microRNA; si, small interfering RNA; NC, negative control; LiCl, lithium chloride; PCa, prostate cancer.
Article Snippet: PCa cells (1×10 5 ) were co-transfected with 250 ng WNT signaling luciferase reporter constructs (TOPflash) (Shanghai GeneChem Co., Ltd.) and 25 ng Renilla luciferase vector (Promega Corporation) using Lipofectamine ® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol.
Techniques: Knockdown, TOPFlash assay, Activity Assay, Western Blot, Expressing, Small Interfering RNA, Negative Control